Juliane Bubeck Wardenburg
Juliane Bubeck Wardenburg, MD, PhD, at WashU Medicine, brings empathy and compassion to families with children in critical care. She also is working on strategies to prevent staph infections in infants.
$14 million supports work to diversify human genome research
WashU Medicine researchers have received two large grants from the NIH renewing funding for the Human Pangenome Reference Sequencing Project.
Study identifies benefits, risks linked to popular weight-loss drugs
People prescribed the popular GLP-1 weight-loss drugs such as Ozempic and Mounjaro may experience benefits such as increased cognitive and behavioral health, according to scientists at WashU Medicine and the Veterans Affairs St. Louis Health Care System. But users may also face increased risks for pancreatitis and kidney conditions, among other illnesses.
Brains of people with sickle cell disease appear older
A new study led by WashU Medicine researchers has found older-looking brains in adults with sickle cell disease, helping to explain the cognitive challenges experienced by such individuals.
Drug in clinical trials for breast cancer could also treat some blood cancers
Research from WashU Medicine found a possible new treatment strategy for certain types of blood cancers.
Fatal neurodegenerative disease in kids also affects the bowel
Researchers at WashU Medicine have described the neurodegeneration that occurs in the nervous system of the bowel in Batten disease, a rare and fatal genetic condition.
New cellular immunotherapy approach shows promise for B-cell lymphoma
A phase 1 clinical trial co-led by researchers at WashU Medicine found that a new type of cell-based immunotherapy was safe for patients with several types of B-cell lymphoma, a type of blood cancer.
Residency Program honored for diversity, equity and inclusion
The Internal Medicine Residency Program at WashU Medicine has received the Accreditation Council for Graduate Medical Education 2025 Barbara Ross-Lee, DO Diversity, Equity, and Inclusion Award.
Immune-targeted approach helps control tuberculosis in mice
Mice infected with the bacteria that cause tuberculosis (TB) fared better when treated with an experimental compound that modulates immune responses, according to a study led by Christina Stallings, a professor of molecular microbiology at WashU Medicine.
Brain structure differences provide clues to substance use risks
Researchers at Washington University found correlations between types of brain structure and people who try drugs before age 15.
View More Stories